Table of Contents:
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope of the Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restrains
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
Chapter 5. Market Factor Analysis
5.1 Porterโs Five Forces Analysis
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Value Chain Analysis
5.3 Investment Feasibility Analysis
5.4 Pricing Analysis
Chapter 6. Global Febrile Seizure Market, by Type
6.1 Introduction
6.2 Simple Febrile Seizure
6.2.1 Market Estimates & Forecast, 2020-2027
6.3 Complex Febrile Seizure
6.3.1 Market Estimates & Forecast, 2020-2027
Chapter 7. Global Febrile Seizure Market, by Diagnosis
7.1 Introduction
7.2 Physical Examination
7.2.1 Market Estimates & Forecast, 2020-2027
7.3 Laboratory Tests
7.3.1 Market Estimates & Forecast, 2020-2027
7.4 Electroencephalogram (EEG)
7.4.1 Market Estimates & Forecast, 2020-2027
7.5 Others
7.5.1 Market Estimates & Forecast, 2020-2027
Chapter 8. Global Febrile Seizure Market, by treatment
8.1 Introduction
8.2 Home Management
8.2.1 Market Estimates & Forecast, 2020-2027
8.3 Antipyretic Medication
8.3.1 Market Estimates & Forecast, 2020-2027
8.4 Others
8.4.1 Market Estimates & Forecast, 2020-2027
Chapter 9. Global Febrile Seizure Market, by Distribution Channel
9.1 Introduction
9.2 Hospitals
9.2.1 Market Estimates & Forecast, 2020-2027
9.3 Clinics
9.3.1 Market Estimates & Forecast, 2020-2027
9.4 Diagnostic Centers
9.4.1 Market Estimates & Forecast, 2020-2027
9.5 Drug Stores
9.5.1 Market Estimates & Forecast, 2020-2027
9.6 Pharmacies
9.6.1 Market Estimates & Forecast, 2020-2027
9.7 Others
9.7.1 Market Estimates & Forecast, 2020-2027
Chapter 10. Global Febrile Seizure Market, by Region
10.1 Introduction
10.2 Americas
10.2.1 North America
10.2.1.1 U.S.
10.2.1.1 Canada
10.2.2 South America
10.3 Europe
10.3.1 Western Europe
10.3.1.1 Germany
10.3.1.2 France
10.3.1.3 Italy
10.3.1.4 Spain
10.3.1.5 U.K
10.3.1.6 Rest of Western Europe
10.3.2 Eastern Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 Republic of Korea
10.4.6 Rest of Asia Pacific
10.5 The Middle East & Africa
10.5.1 United Arab Emirates
10.5.2 Saudi Arabia
10.5.3 Oman
10.5.4 Kuwait
10.5.5 Qatar
10.5.6 Rest of the Middle East & Africa
Chapter 11 Company Landscape
11.1 Introduction
11.2 Market Share Analysis
11.3 Key Development & Strategies
11.3.1 Key Developments
Chapter 12 Company Profiles
12.1 Sanofi
12.1.1 Company Overview
12.1.2 Types Overview
12.1.3 Financials
12.1.4 SWOT Analysis
12.2 Cardinal Health
12.2.1 Company Overview
12.2.2 Types Overview
12.2.3 Financial Overview
12.2.4 Key Developments
12.2.5 SWOT Analysis
12.3 Merck
12.3.1 Company Overview
12.3.2 Types Overview
12.3.3 Financial Overview
12.3.4 Key Development
12.3.5 SWOT Analysis
12.4 Pfizer
12.4.1 Company Overview
12.4.2 Types/Business Segment Overview
12.4.3 Financial Overview
12.4.4 Key Development
12.4.5 SWOT Analysis
12.5 Johnson & Johnson
12.5.1 Company Overview
12.5.2 Types Overview
12.5.3 Financial overview
12.5.4 Key Developments
12.6 Johnson & Johnson Private Limited
12.6.1 Company Overview
12.6.2 Types Overview
12.6.3 Financial Overview
12.6.4 Key Developments
12.7 ABBOTT LABORATORIES
12.7.1 Overview
12.7.2 Types Overview
12.7.3 Financials
12.7.4 Key Developments
12.7.5 SWOT Analysis
12.8 Others
Chapter 12 MRFR Conclusion
12.1 Key Findings
12.1.1 From CEOโs View Point
12.1.2 Unmet Needs of the Market
12.2 Key Companies to Watch
12.3 Prediction of Febrile Seizure industry
Chapter 13 Appendix
LIST OF TABLES
Table 1 Febrile Seizure Industry Synopsis, 2020-2027
Table 2 Febrile Seizure Market Estimates and Forecast, 2020-2027, (USD Million)
Table 3 Febrile Seizure Market by Region, 2020-2027, (USD Million)
Table 4 Febrile Seizure Market by Type, 2020-2027, (USD Million)
Table 5 Febrile Seizure Market by Diagnosis, 2020-2027, (USD Million)
Table 6 Febrile Seizure Market by Treatment, 2020-2027, (USD Million)
Table 7 Febrile Seizure Market by Distribution Channels, 2020-2027, (USD Million)
Table 8 North America Febrile Seizure Market by Type, 2020-2027, (USD Million)
Table 9 North America Febrile Seizure Market by Diagnosis, 2020-2027, (USD Million)
Table 10 North America Febrile Seizure Market by Treatment, 2020-2027, (USD Million)
Table 11 North America Febrile Seizure Market by Distribution Channels, 2020-2027, (USD Million)
Table 12 US Febrile Seizure Market by Type, 2020-2027, (USD Million)
Table 13 US Febrile Seizure Market by Diagnosis, 2020-2027, (USD Million)
Table 14 US Febrile Seizure Market by Treatment, 2020-2027, (USD Million)
Table 15 US Febrile Seizure Market by Distribution Channels, 2020-2027, (USD Million)
Table 16 Canada Febrile Seizure Market by Type, 2020-2027, (USD Million)
Table 17 Canada Febrile Seizure market by Diagnosis, 2020-2027, (USD Million)
Table 18 Canada Febrile Seizure Market by Treatment, 2020-2027, (USD Million)
Table 19 Canada Febrile Seizure market by Distribution Channels, 2020-2027, (USD Million)
Table 20 South America Febrile Seizure Market by Type, 2020-2027, (USD Million)
Table 21 South America Febrile Seizure Market by Diagnosis, 2020-2027, (USD Million)
Table 22 South America Febrile Seizure Market by Treatment, 2020-2027, (USD Million)
Table 23 South America Febrile Seizure Market by Distribution Channels, 2020-2027, (USD Million)
Table 24 Europe Febrile Seizure Market by Type, 2020-2027, (USD Million)
Table 25 Europe Febrile Seizure Market by Diagnosis, 2020-2027, (USD Million)
Table 26 Europe Febrile Seizure Market by Treatment, 2020-2027, (USD Million)
Table 27 Europe Febrile Seizure Market by Distribution Channels, 2020-2027, (USD Million)
Table 28 Western Europe Febrile Seizure Market by Type, 2020-2027, (USD Million)
Table 29 Western Europe Febrile Seizure Market by Diagnosis, 2020-2027, (USD Million)
Table 30 Western Europe Febrile Seizure Market by Treatment, 2020-2027, (USD Million)
Table 31 Western Europe Febrile Seizure Market by Distribution Channels, 2020-2027, (USD Million)
Table 32 Eastern Europe Febrile Seizure Market by Type, 2020-2027, (USD Million)
Table 33 Eastern Europe Febrile Seizure market by Diagnosis, 2020-2027, (USD Million)
Table 34 Eastern Europe Febrile Seizure Market by Treatment, 2020-2027, (USD Million)
Table 35 Eastern Europe Febrile Seizure Market by Distribution Channels, 2020-2027, (USD Million)
Table 36 Asia Pacific Febrile Seizure Market by Type, 2020-2027, (USD Million)
Table 37 Asia Pacific Febrile Seizure Market by Diagnosis, 2020-2027, (USD Million)
Table 38 Asia Pacific Febrile Seizure Market by Treatment, 2020-2027, (USD Million)
Table 39 Asia Pacific Febrile Seizure market by Distribution Channels, 2020-2027, (USD Million)
Table 40 Middle East & Africa Febrile Seizure Market by Type, 2020-2027, (USD Million)
Table 41 Middle East & Africa Febrile Seizure Market by Diagnosis, 2020-2027, (USD Million)
Table 42 Middle East & Africa Febrile Seizure Market by Treatment, 2020-2027, (USD Million)
Table 43 Middle East & Africa Febrile Seizure market by Distribution Channels, 2020-2027, (USD Million)
LIST OF FIGURES
Figure 1 Research Process
Figure 2 Segmentation for Febrile Seizure Market
Figure 3 Segmentation Market Dynamics for Febrile Seizure Market
Figure 4 Global Febrile Seizure market Share, by Type 2020
Figure 5 Global Febrile Seizure market Share, by Diagnosis 2020
Figure 6 Global Febrile Seizure market Share, by Treatment 2020
Figure 7 Global Febrile Seizure market Share, by Distribution Channels, 2020
Figure 8 Global Febrile Seizure market Share, by Region, 2020
Figure 9 North America Febrile Seizure market Share, by Country, 2020
Figure 10 Europe Febrile Seizure market Share, by Country, 2020
Figure 11 Asia Pacific Febrile Seizure market Share, by Country, 2020
Figure 12 Middle East & Africa Febrile Seizure market Share, by Country, 2020
Figure 13 Global Febrile Seizure market: Company Share Analysis, 2020 (%)
Figure 14 Sanofi: Key Financials
Figure 15 Sanofi Segmental Revenue
Figure 16 Sanofi: Geographical Revenue
Figure 17 Cardinal Health: Key Financials
Figure 18 Cardinal Health: Segmental Revenue
Figure 19 Cardinal Health: Geographical Revenue
Figure 20 Merck: Key Financials
Figure 21 Merck: Segmental Revenue
Figure 22 Merck: Geographical Revenue
Figure 23 Pfizer: Key Financials
Figure 24 Pfizer: Segmental Revenue
Figure 25 Pfizer: Geographical Revenue
Figure 26 Johnson & Johnson: Key Financials
Figure 27 Johnson & Johnson: Segmental Revenue
Figure 28 Johnson & Johnson Geographical Revenue
Figure 29 Johnson & Johnson Private Limited: Key Financials
Figure 30 Johnson & Johnson Private Limited: Segmental Revenue
Figure 31 Johnson & Johnson Private Limited: Geographical Revenue
Figure 32 ABBOTT LABORATORIES: Key Financials
Figure 33 ABBOTT LABORATORIES: Segmental Revenue
Figure 34 ABBOTT LABORATORIES: Geographical Revenue